{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T05:20:35Z","timestamp":1761888035189,"version":"build-2065373602"},"reference-count":60,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Portuguesa de Cardiologia (English Edition)"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.repce.2020.09.003","type":"journal-article","created":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T19:49:53Z","timestamp":1617738593000},"page":"371-382","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Non\u2010pharmacological treatment of refractory angina: The coronary sinus reducer, the new kid on the block"],"prefix":"10.1016","volume":"40","author":[{"given":"S\u00e9rgio","family":"Madeira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Br\u00edzido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu\u00eds","family":"Raposo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Brito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00e9lson","family":"Vale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvio","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pedro de Ara\u00fajo","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henrique Mesquita","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui Campante","family":"Teles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.repce.2020.09.003_bib0005","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2020","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.repce.2020.09.003_bib0010","first-page":"S50","article-title":"Patients with coronary artery disease unsuitable for revascularization: definition, general principles, and a classification","volume":"28","author":"Jolicoeur","year":"2012","journal-title":"Can J Cardiol"},{"issue":"5","key":"10.1016\/j.repce.2020.09.003_bib0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1053\/euhj.2001.2706","article-title":"The problem of chronic refractory angina: report from the ESC Joint Study Group on the treatment of refractory angina","volume":"23","author":"Mannheimer","year":"2002","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.repce.2020.09.003_bib0020","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/hrt.81.5.470","article-title":"Appropriateness of referral of coronary angiography patients in Sweden","volume":"81","author":"Bernstein","year":"1999","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.repce.2020.09.003_bib0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1136\/heart.87.2.140","article-title":"Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population","volume":"87","author":"Brorsson","year":"2002","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.repce.2020.09.003_bib0030","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0002-9149(99)00387-2","article-title":"Direct myocardial revascularization and angiogenesis - How many patients might be eligible?","volume":"84","author":"Mukherjee","year":"1999","journal-title":"Am J Cardiol"},{"issue":"6","key":"10.1016\/j.repce.2020.09.003_bib0035","first-page":"886","article-title":"Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality","volume":"75","author":"Williams","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"issue":"12","key":"10.1016\/j.repce.2020.09.003_bib0040","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/eurheartj\/ehi238","article-title":"Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization","volume":"26","author":"Lenzen","year":"2005","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.repce.2020.09.003_bib0045","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejcnurse.2006.01.003","article-title":"Pharmacological treatment and perceived health status during 1-year follow up in patients diagnosed with coronary artery disease, but ineligible for revascularization. Results from the Euro Heart Survey on Coronary Revascularization","volume":"5","author":"Lenzen","year":"2006","journal-title":"Eur J Cardiovasc Nurs"},{"issue":"34","key":"10.1016\/j.repce.2020.09.003_bib0050","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1093\/eurheartj\/eht165","article-title":"Long-term survival in patients with refractory angina","volume":"34","author":"Henry","year":"2013","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.repce.2020.09.003_bib0055","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1097\/MCA.0000000000000560","article-title":"Long-term risk and predictors of cardiovascular death in stable coronary artery disease: the CORONOR study","volume":"28","author":"Bauters","year":"2017","journal-title":"Coron Artery Dis"},{"issue":"10","key":"10.1016\/j.repce.2020.09.003_bib0060","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.107.743963","article-title":"Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) trial nuclear substudy","volume":"117","author":"Shaw","year":"2008","journal-title":"Circulation"},{"issue":"9867","key":"10.1016\/j.repce.2020.09.003_bib0065","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(13)60141-5","article-title":"Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial","volume":"381","author":"Mohr","year":"2013","journal-title":"Lancet"},{"issue":"15","key":"10.1016\/j.repce.2020.09.003_bib0070","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial invasive or conservative strategy for stable coronary disease","volume":"382","author":"Maron","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.repce.2020.09.003_bib0075","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001287","article-title":"Predictors of long-term clinical endpoints in patients with refractory angina","volume":"4","author":"Povsic","year":"2015","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"10.1016\/j.repce.2020.09.003_bib0080","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1001\/jamainternmed.2014.3773","article-title":"Prevalence of anginal symptoms and myocardial ischemia and their effect on clinical outcomes in outpatients with stable coronary artery disease data from the international observational CLARIFY registry","volume":"174","author":"Steg","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"23","key":"10.1016\/j.repce.2020.09.003_bib0085","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1136\/heartjnl-2015-308564","article-title":"Alternative interventions for refractory angina","volume":"103","author":"Sainsbury","year":"2017","journal-title":"Heart"},{"issue":"2","key":"10.1016\/j.repce.2020.09.003_bib0090","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/nrcardio.2017.131","article-title":"Expert consensus document: a \u2018diamond\u2019 approach to personalized treatment of angina","volume":"15","author":"Ferrari","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.repce.2020.09.003_bib0095","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nrcardio.2013.200","article-title":"Treatment of refractory angina in patients not suitable for revascularization","volume":"11","author":"Henry","year":"2014","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"10.1016\/j.repce.2020.09.003_bib0100","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0735-1097(99)00140-0","article-title":"The multicenter study of enhanced external counterpulsation (MUST-EECP): Effect of EECP on exercise-induced myocardial ischemia and anginal episodes","volume":"33","author":"Arora","year":"1999","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.repce.2020.09.003_bib0105","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/eci.12546","article-title":"Clinical effect of cardiac shock wave therapy on patients with ischaemic heart disease: a systematic review and meta-analysis","volume":"45","author":"Wang","year":"2015","journal-title":"Eur J Clin Invest"},{"issue":"26","key":"10.1016\/j.repce.2020.09.003_bib0110","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1093\/eurheartj\/ehy220","article-title":"A randomized multicentre trial to compare revascularization with optimal medical therapy for the treatment of chronic total coronary occlusions","volume":"39","author":"Werner","year":"2018","journal-title":"Eur Heart J"},{"issue":"14","key":"10.1016\/j.repce.2020.09.003_bib0115","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.118.031313","article-title":"Randomized trial evaluating percutaneous coronary intervention for the treatment of chronic total occlusion: the DECISION-CTO trial","volume":"139","author":"Lee","year":"2019","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.repce.2020.09.003_bib0120","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1016\/j.jacc.2005.06.079","article-title":"A blinded, randomized, placebo-controlled trial of percutaneous laser myocardial revascularization to improve angina symptoms in patients with severe coronary disease","volume":"46","author":"Leon","year":"2005","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.repce.2020.09.003_bib0125","article-title":"Transmyocardial laser revascularization versus medical therapy for refractory angina","author":"Briones","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"17","key":"10.1016\/j.repce.2020.09.003_bib0130","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.jacc.2007.01.061","article-title":"Coronary sinus reducer stent for the treatment of chronic refractory angina pectoris. A prospective, open-label, multicenter, safety feasibility first-in-man study","volume":"49","author":"Banai","year":"2007","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.repce.2020.09.003_bib0135","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.4244\/EIJV9I10A196","article-title":"Transcatheter treatment for refractory angina with the coronary sinus Reducer","volume":"9","author":"Konigstein","year":"2014","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1016\/j.repce.2020.09.003_bib0140","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJMoa1402556","article-title":"Efficacy of a device to narrow the coronary sinus in refractory Angina","volume":"372","author":"Verheye","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.repce.2020.09.003_bib0145","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s12471-016-0862-2","article-title":"Safety and efficacy of a device to narrow the coronary sinus for the treatment of refractory angina: a single-centre real-world experience","volume":"24","author":"Abawi","year":"2016","journal-title":"Netherlands Heart J"},{"key":"10.1016\/j.repce.2020.09.003_bib0150","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1093\/eurheartj\/ehx486","article-title":"The Reducer device in patients with angina pectoris: mechanisms, indications, and perspectives","volume":"39","author":"Konigstein","year":"2018","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.repce.2020.09.003_bib0155","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.jcin.2018.01.251","article-title":"Coronary sinus reducer implantation for the treatment of chronic refractory Angina: a single-center experience","volume":"11","author":"Giannini","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repce.2020.09.003_bib0160","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ijcard.2018.06.116","article-title":"Safety and efficacy of the reducer: a multi-center clinical registry - REDUCE study","volume":"269","author":"Giannini","year":"2018","journal-title":"Int J Cardiol"},{"issue":"6","key":"10.1016\/j.repce.2020.09.003_bib0165","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/CIRCRESAHA.115.308056","article-title":"Impact of cell therapy on myocardial perfusion and cardiovascular outcomes in patients with angina refractory to medical therapy: a systematic review and meta-analysis","volume":"118","author":"Khan","year":"2016","journal-title":"Circ Res"},{"issue":"15","key":"10.1016\/j.repce.2020.09.003_bib0170","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.jcin.2016.05.003","article-title":"The RENEW trial: efficacy and safety of intramyocardial autologous CD34+ cell administration in patients with refractory Angina","volume":"9","author":"Povsic","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.repce.2020.09.003_bib0175","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2261-9-13","article-title":"Spinal cord stimulation in the treatment of refractory angina: systematic review and meta-analysis of randomised controlled trials","author":"Taylor","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"issue":"14","key":"10.1016\/j.repce.2020.09.003_bib0180","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/hrt.2009.177188","article-title":"Long-term effects of spinal cord stimulation on angina symptoms and quality of life in patients with refractory angina pectoris - results from the European Angina Registry Link Study (EARL)","volume":"96","author":"Andr\u00e9ll","year":"2010","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.repce.2020.09.003_bib0185","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/ner.12349","article-title":"The effectiveness and cost-effectiveness of spinal cord stimulation for refractory angina (RASCAL study): a pilot randomized controlled trial","volume":"19","author":"Eldabe","year":"2016","journal-title":"Neuromodulation"},{"issue":"12","key":"10.1016\/j.repce.2020.09.003_bib0190","first-page":"1011","article-title":"The history of cardiac catheterization","volume":"21","author":"Bourassa","year":"2005","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.repce.2020.09.003_bib0195","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1001\/jama.1952.02930160008003","article-title":"History of the treatment of coronary heart disease","volume":"148","author":"NC","year":"1952","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.repce.2020.09.003_bib0200","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S0003-4975(96)01375-6","article-title":"The history of surgery for ischemic heart disease","volume":"63","author":"Mueller","year":"1997","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.repce.2020.09.003_bib0205","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.0954-6820.1963.tb07895.x","article-title":"The beck\u2010I operation for Angina pectoris medical aspects","volume":"174","author":"Wising","year":"1963","journal-title":"Acta Med Scand"},{"issue":"7","key":"10.1016\/j.repce.2020.09.003_bib0210","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0002-9149(84)90526-5","article-title":"Reduction of infarct size induced by pressure-controlled intermittent coronary sinus occlusion","volume":"53","author":"Mohl","year":"1984","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.repce.2020.09.003_bib0215","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0003-4975(10)65897-3","article-title":"Clinical evaluation of pressure-controlled intermittent coronary sinus occlusion: randomized trial during coronary artery surgery","volume":"46","author":"Mohl","year":"1988","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.repce.2020.09.003_bib0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4244\/EIJY15M03_10","article-title":"Pressure-controlled intermittent coronary sinus occlusion (PICSO) in acute ST-segment elevation myocardial infarction: results of the Prepare RAMSES safety and feasibility study","volume":"11","author":"Van De","year":"2015","journal-title":"EuroIntervention"},{"issue":"8","key":"10.1016\/j.repce.2020.09.003_bib0225","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMra061889","article-title":"Coronary microvascular dysfunction","volume":"356","author":"Camici","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.repce.2020.09.003_bib0230","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.ijcard.2016.02.018","article-title":"Coronary Sinus Reducer system\u2122: a new therapeutic option in refractory angina patients unsuitable for revascularization","volume":"209","author":"Ielasi","year":"2016","journal-title":"Int J Cardiol"},{"issue":"3","key":"10.1016\/j.repce.2020.09.003_bib0235","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1152\/physrev.00045.2006","article-title":"Regulation of coronary blood flow during exercise","volume":"88","author":"Duncker","year":"2008","journal-title":"Physiol Rev"},{"issue":"3","key":"10.1016\/j.repce.2020.09.003_bib0240","doi-asserted-by":"crossref","first-page":"H1361","DOI":"10.1152\/ajpheart.2001.280.3.H1361","article-title":"Coronary sinus occlusion enhances coronary collateral flow and reduces subendocardial ischemia","volume":"280","author":"Ido","year":"2001","journal-title":"Am J Physiol - Heart Circ Physiol"},{"issue":"1","key":"10.1016\/j.repce.2020.09.003_bib0245","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/14779072.2017.1270755","article-title":"The coronary sinus reducer: clinical evidence and technical aspects","volume":"15","author":"Giannini","year":"2017","journal-title":"Expert Rev Cardiovasc Ther"},{"year":"2014","author":"Banai","key":"10.1016\/j.repce.2020.09.003_bib0250"},{"issue":"10_Supplement","key":"10.1016\/j.repce.2020.09.003_bib0255","article-title":"Long-term follow-up to evaluate the safety of the Neovasc Reducer a device based therapy for chronic refractory angina","volume":"55","author":"Banai","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.repce.2020.09.003_bib0260","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0895-4356(00)00206-7","article-title":"Do medical devices have enhanced placebo effects?","volume":"53","author":"Kaptchuk","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.repce.2020.09.003_bib0265","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0002-8703(96)90465-2","article-title":"The placebo effect in cardiovascular disease","volume":"132","author":"Bienenfeld","year":"1998","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.repce.2020.09.003_bib0270","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.4244\/EIJ-D-18-00102","article-title":"Coronary Sinus Reducer implantation improves symptoms, ischaemia and physical capacity in patients with refractory angina unsuitable for myocardial revascularisation: a single-centre experience","volume":"14","author":"Konigstein","year":"2018","journal-title":"EuroIntervention"},{"issue":"18","key":"10.1016\/j.repce.2020.09.003_bib0275","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jcin.2017.06.062","article-title":"First experience with the coronary sinus reducer system for the management of refractory Angina in patients without obstructive coronary artery disease","volume":"10","author":"Giannini","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"7","key":"10.1016\/j.repce.2020.09.003_bib0280","first-page":"466","article-title":"[The coronary sinus reducer: a device-based therapy for refractory Angina]. The coronary sinus reducer: a device-based therapy for refractory Angina","volume":"156","author":"Konigstein","year":"2017","journal-title":"Harefuah"},{"key":"10.1016\/j.repce.2020.09.003_bib0285","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.4244\/EIJ-D-17-00626","article-title":"Coronary sinus reducer non-responders: insights and perspectives","volume":"13","author":"Baldetti","year":"2018","journal-title":"EuroIntervention"},{"issue":"1","key":"10.1016\/j.repce.2020.09.003_bib0290","first-page":"32","article-title":"Cost-effectiveness of the coronary sinus Reducer and its impact on the healthcare burden of refractory angina patients","volume":"6","author":"Gallone","year":"2020","journal-title":"Eur Hear J - Qual Care Clin Outcomes"},{"year":"2003","series-title":"Making Choices in Health: WHO Guide to Cost-Effectiveness Analysis. Global Programme on Evidence for Health Policy","author":"WHO-CHOICE","key":"10.1016\/j.repce.2020.09.003_bib0295"},{"issue":"1","key":"10.1016\/j.repce.2020.09.003_bib0300","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European society of cardiology: cardiovascular disease statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"}],"container-title":["Revista Portuguesa de Cardiologia (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2174204921000660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2174204921000660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:40:38Z","timestamp":1761882038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2174204921000660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2174204921000660"],"URL":"https:\/\/doi.org\/10.1016\/j.repce.2020.09.003","relation":{},"ISSN":["2174-2049"],"issn-type":[{"type":"print","value":"2174-2049"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non\u2010pharmacological treatment of refractory angina: The coronary sinus reducer, the new kid on the block","name":"articletitle","label":"Article Title"},{"value":"Revista Portuguesa de Cardiologia (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.repce.2020.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.repc.2020.09.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Sociedade Portuguesa de Cardiologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}